Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.

about

New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.

P2860

Q49815957-47067B59-DCAC-4E52-A1A1-6826BDCF9966

P2860

Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.

Item

http://www.wikidata.org/entity/Q36592576

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@ast

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@en

type

Item

label

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@ast

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@en

prefLabel

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@ast

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@en

P1476

Controlled Release of Dexameth ...... Using Porous Silicon Dioxide.

@en

P2093

Chengyun Wang

http://www.w3.org/2001/XMLSchema#string

Huiyuan Hou

http://www.w3.org/2001/XMLSchema#string

Kaihui Nan

http://www.w3.org/2001/XMLSchema#string

Lingyun Cheng

http://www.w3.org/2001/XMLSchema#string

Michael J Sailor

http://www.w3.org/2001/XMLSchema#string

William R Freeman

http://www.w3.org/2001/XMLSchema#string

P2860

The prevalence of age-related eye diseases and visual impairment in aging: current estimates

A Novel Technique for Repositioning of a Migrated ILUVIEN(®) (Fluocinolone Acetonide) Implant into the Anterior Chamber.

Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.

Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.

Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.

P304

557-566

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.15-18559

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26882530

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

P932

4758302

http://www.w3.org/2001/XMLSchema#string

Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.

about

P2860

P2860

Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932